美国Vasomedical
美国Vasomedical公司体外反搏治疗法EECP

Vasomedical, Inc. engages in the design, manufacture, marketing, and supporting of EECP external counterpulsation systems for the treatment of diseases of the cardiovascular system. Its EECP therapy system is indicated for use in cases of stable or unstable angina, congestive heart failure, acute myocardial infarction, and cardiogenic shock. The therapy serves to increase circulation in areas of the heart with less than adequate blood supply and helps to restore systemic vascular function; and increases blood flow and oxygen supply to the heart muscle and other organs, and decreases the heart's workload and need for oxygen. The company provides its EECP equipment, treatment guidance, and a staff training and equipment maintenance program to hospitals, clinics, and physician private practices. Vasomedical sells EECP therapy systems in the United States through a direct and indirect sales force; and distributes its product internationally through a network of independent distributors. The company was founded in 1987 and is headquartered in Westbury, New York.